InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
2
T+90 hit rate
33%
T+90 mean return
-5.6%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Sohn Catherine A., Administratrice. Officer active across 3 companies, notably Landec CORP \ca\. Cumulatively, 10 reports have been logged. Breakdown: 1 buy · 2 sells. Total volume traded: €332k. Activity tracked since 1 June 2021. The latest transaction was disclosed on 17 March 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations10 total
1,000 shares@ US$5.7845100.0% of flowCommon Stock, par value $0.0001SEC:0001104659-25-025032:0
Ideal exit: 12 Dec 2025 (T+270)
3,075 shares0Ordinary SharesSEC:0001765581-23-000092:0
2,561 shares0Ordinary SharesSEC:0001765581-22-000100:0
7,059 shares@ US$9.5028.3% of flowCommon StockSEC:0001628280-22-016485:0
1,306 shares@ US$147.9650.0% of flowOrdinary SharesSEC:0001765581-21-000110
1,306 shares@ US$147.960.0011% mcap50.0% of flowOrdinary SharesSEC:0001765581-21-000110:0
2,246 shares0Ordinary SharesSEC:0001765581-21-000085
2,246 shares0Ordinary SharesSEC:0001765581-21-000085:0
8,303 shares@ US$11.6435.9% of flowCommon StockSEC:0001593968-21-001522:0
8,303 shares@ US$11.6435.9% of flowCommon StockSEC:0001593968-21-001522
10 of 10 declarations
About Sohn Catherine A.
Catherine A. Sohn is a Board Member at Landec Corp. and Jazz Pharmaceuticals plc. In this role, she contributes to the governance and strategy of these companies. Catherine has extensive experience in the pharmaceutical and biotechnology sectors, having held various leadership positions. Her expertise in product development and business strategy is a valuable asset for guiding Landec and Jazz towards innovation.
